[HTML][HTML] Prevalencia y factores asociados al consumo de tabaco en alumnos de enseñanza secundaria de Cataluña
D Puente, E Zabaleta-del-Olmo, MJ Pueyo, E Saltó… - Atención Primaria, 2013 - Elsevier
Objetivos Analizar aquellos factores asociados al consumo de tabaco en adolescentes para
plantear futuras intervenciones de promoción de la salud desarrolladas por las escuelas y …
plantear futuras intervenciones de promoción de la salud desarrolladas por las escuelas y …
[HTML][HTML] Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
XS Puente, M Pinyol, V Quesada, L Conde… - Nature, 2011 - nature.com
Chronic lymphocytic leukaemia (CLL), the most frequent leukaemia in adults in Western
countries, is a heterogeneous disease with variable clinical presentation and evolution 1 , 2 . …
countries, is a heterogeneous disease with variable clinical presentation and evolution 1 , 2 . …
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
Here we perform whole-exome sequencing of samples from 105 individuals with chronic
lymphocytic leukemia (CLL) 1 , 2 , the most frequent leukemia in adults in Western countries. …
lymphocytic leukemia (CLL) 1 , 2 , the most frequent leukemia in adults in Western countries. …
Non-coding recurrent mutations in chronic lymphocytic leukaemia
Chronic lymphocytic leukaemia (CLL) is a frequent disease in which the genetic alterations
determining the clinicobiological behaviour are not fully understood. Here we describe a …
determining the clinicobiological behaviour are not fully understood. Here we describe a …
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
…, P Vizán, L Di Croce, DA Puente… - Proceedings of the …, 2013 - National Acad Sciences
Mantle cell lymphoma (MCL) is an aggressive tumor, but a subset of patients may follow an
indolent clinical course. To understand the mechanisms underlying this biological …
indolent clinical course. To understand the mechanisms underlying this biological …
P53 as a prognostic marker for bladder cancer: a meta-analysis and review
…, F Fernandez, M Rivas, D Puente… - The lancet …, 2005 - thelancet.com
Background P53 is the most widely investigated molecular marker in bladder cancer. We
aimed to review comprehensively the evidence for use of changes in P53 to predict bladder-…
aimed to review comprehensively the evidence for use of changes in P53 to predict bladder-…
[HTML][HTML] POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing …
…, G Aiza, R Valdés-Mas, M Navarro, DA Puente… - Genetics in …, 2016 - nature.com
Purpose: Germ-line mutations in the exonuclease domains of POLE and POLD1 have been
recently associated with polyposis and colorectal cancer (CRC) predisposition. Here, we …
recently associated with polyposis and colorectal cancer (CRC) predisposition. Here, we …
[PDF][PDF] Exome sequencing and functional analysis identifies BANF1 mutation as the cause of a hereditary progeroid syndrome
XS Puente, V Quesada, FG Osorio, R Cabanillas… - The American Journal of …, 2011 - cell.com
Accelerated aging syndromes represent a valuable source of information about the molecular
mechanisms involved in normal aging. Here, we describe a progeroid syndrome that …
mechanisms involved in normal aging. Here, we describe a progeroid syndrome that …
[HTML][HTML] Mutations in filamin C cause a new form of familial hypertrophic cardiomyopathy
…, J Gómez, E Coto, A Astudillo, DA Puente… - Nature …, 2014 - nature.com
Mutations in different genes encoding sarcomeric proteins are responsible for 50–60% of
familial cases of hypertrophic cardiomyopathy (HCM); however, the genetic alterations causing …
familial cases of hypertrophic cardiomyopathy (HCM); however, the genetic alterations causing …
Altered patterns of global protein synthesis and translational fidelity in RPS15-mutated chronic lymphocytic leukemia
Genomic studies have recently identified RPS15 as a new driver gene in aggressive and
chemorefractory cases of chronic lymphocytic leukemia (CLL). RPS15 encodes a ribosomal …
chemorefractory cases of chronic lymphocytic leukemia (CLL). RPS15 encodes a ribosomal …